BAKER BROS. ADVISORS LP Verve Therapeutics, Inc. Transaction History

BAKER BROS. ADVISORS LP portfolio value:

$48.65M
portfolio value

BAKER BROS. ADVISORS LP quarter portfolio value change:

+124.80%
quarter

Verve Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 27.01M $34.35 1.41M
Q2 2022 share 0.00% 0 shares -10.68M $15.28 1.41M
Q1 2022 share 0.00% 0 shares -19.90M $22.82 1.41M
Q4 2021 share 0.00% 0 shares -14.35M $37.72 1.41M
Q3 2021 share 0.00% 0 shares -18.76M $47 1.41M
Q2 2021 share Increase 0.00% 1.41M shares 85.34M $60.25 1.41M